Evofem Biosciences, Inc. provided sales guidance for the third quarter of 2023. For the expects sales to be $5.0 million to $5.2 million for the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0168 USD | +17.96% | +9.09% | -73.75% |
1st Jan change | Capi. | |
---|---|---|
-73.75% | 929K | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023